Meeting
2017 Genitourinary Cancers Symposium
Investigation on relationships between reduction of cisplatin and anticancer effects in patients with bladder cancer.
Authors
Yasuyoshi Miyata
Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Yasuyoshi Miyata , Tomohiro Matsuo , Kojiro Ohba , Hideki Sakai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Prostate Cancer,Urothelial Carcinoma,Prostate Cancer
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 306)
DOI
10.1200/JCO.2017.35.6_suppl.306
Abstract #
306
Poster Bd #
E19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Oncological outcome of intraarterial chemotherapy combined with radiotherapy compared to radical cystectomy for patients with muscle invasive bladder cancer.
First Author: Katsuyoshi Higashijima
Poster
2024 ASCO Genitourinary Cancers Symposium
Efficacy and safety of the combination of cisplatin plus nab-paclitaxel and nivolumab with radiotherapy after maximal tumor resection in non-metastatic muscle invasive bladder cancer (CNN-BC trial).
First Author: Chiara Ciccarese
Poster
2024 ASCO Genitourinary Cancers Symposium
Characteristics, treatment patterns, and clinical outcomes of patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer in the real world.
First Author: Patrick Squires
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling proteomic diversity: A quantitative study of antibody drug conjugate and chemotherapy targets in gastroesophageal cancer.
First Author: Sheeno P. Thyparambil